Cambridge Uni's 'Quartet Nanocage' Vaccine Targets All Coronaviruses

May 6, 2024, 03:25 PM

Researchers at Cambridge University have developed a groundbreaking vaccine technology, known as proactive vaccinology, which offers protection against a wide range of coronaviruses, including those not yet discovered. This new approach utilizes a 'quartet nanocage' structure to build immunity against potential future pathogens. The vaccine has shown effectiveness in mice and is designed to preemptively combat the threats of upcoming pandemics.